Search
Skip to Search Results- 2Brian Chwyl
- 2Sandra Campbell
- 1Albo, Susan Karin.
- 1Baillie, Devin MJ
- 1Baldwin, Lesley
- 1Beesley, Richelle Marie
- 5Department of Physics
- 4Department of Oncology
- 2School of Public Health
- 1Department of Agricultural, Food and Nutritional Science
- 1Department of Applied Sciences in Medicine
- 1Department of Chemistry
- 1Andrew, Jeffery (University of British Columbia Okanagan)
- 1Clandinin, M Tom (Agricultural, Food and Nutritional Science)
- 1Compton, Sharon (Dentistry)
- 1Courneya, Kerry (Kinesiology, Sport, and Recreation)
- 1Dinu, Irina (School of Public Health)
- 1Dr. Gino Fallone, Physics\Oncology, University of Alberta
-
A review of select journals in radiation therapy
2015-03-01
A comparative, but non-exhaustive, review of several key journal in the fields of radiation therapy and radiation oncology.
-
Fall 2010
A 9.4 T magnetic resonance imaging (MRI) system was used to evaluate the response of a human tumour xenograft model to radiation therapy. The apparent diffusion coefficient (ADC) and the transverse relaxation time (T2) of human glioblastoma multiforme (GBM) tumour xenografts in NIH-iii nude mice...
-
Comparison of tooth loss between intensity modulated and non-intensity modulated radiotherapy in head and neck cancer patients
DownloadFall 2011
Advanced radiotherapy (RT) systems (intensity modulated radiotherapy, IMRT) is widely used to treat head and neck cancer. A combination of radiation and chemotherapy potentially increases toxicity as well as dental complications. Tooth loss was retrospectively assessed using oral cavity,...
-
Design and simulation of a short, 10 MV, variable energy linear accelerator for use in linac-MR systems
DownloadFall 2016
Hybrid linac-MR devices are currently being designed and constructed by several groups around the world which combine a linear accelerator with an MRI in order to enable real-time 3D imaging to visualize tumor movement during external beam radiotherapy treatments. Each of the current systems is...
-
Spring 2021
Background: Prostate cancer treatments often lead to side effects including sexual and urinary dysfunction as well as fatigue and poor quality of life. As a means of avoiding these side effects, active surveillance has been introduced as a strategy to manage men with low- to moderate-grade...
-
Ganglioside Increases Metastatic Potential and Susceptibility of Prostate Cancer to Gene Therapy in vitro
DownloadFall 2009
Prostate cancer (CaP) is the 2nd most common cancer in North American men. Tumour management strategies are appropriate for early stage disease, but advanced disease has a poor prognosis and requires prompt treatment. Therefore, research into delay of tumour progression and efficacious treatment...
-
Guiding treatment selection for advanced prostate cancer with biogenic silver nanoparticles
DownloadFall 2018
Prostate cancer (PCa) is the second most common cancer in men worldwide. Men with advanced PCa often face poor prognosis and are at high risk for mortality. To improve prognosis in this high risk population, targeting a reliable biological factor or marker that predicts a patient’s response...
-
Impact of conventional fractionated RT to pelvic lymph nodes and dose-escalated hypofractionated RT to prostate gland using IMRT treatment delivery in high-risk prostate cancer
DownloadFall 2009
Prostate cancer is the most common cancer among Canadian men. The standard treatment in high-risk category is radical radiation, with androgen suppression treatment (AST). Significant disease progression is reported despite this approach. Radiation dose escalation has been shown to improve...
-
Investigating Radiation in Combination with Oncolytic Vaccinia Virus to Improve the Treatment of Glioblastoma
DownloadFall 2023
Glioblastoma (GBM) is a malignant and immune-suppressed brain cancer that remains incurable despite the current standard of care. Radiotherapy is a mainstay of GBM treatment, however invasive cancer cells outside the irradiated field and radioresistance preclude complete eradication of GBM cells....